Controlling use of antimicrobials in a community teaching hospital

Infection Control and Hospital Epidemiology

Volumn 27, Issue 3, 2006, Pages 239-244

  Philmon, Carla ^a   Smith, Terri ^a   Williamson, Sharon ^a   Goodman, Edward ^a  

^a PRESBYTERIAN HOSPITAL OF DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CLINDAMYCIN; COTRIMOXAZOLE; DALFOPRISTIN PLUS QUINUPRISTIN; ERTAPENEM; FLUCONAZOLE; GENTAMICIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; METICILLIN; METRONIDAZOLE; MINOCYCLINE; MOXIFLOXACIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; COMMUNITY HOSPITAL; DRUG COST; DRUG DOSE REGIMEN; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MEDICAL ORDER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHYSICIAN; POSTOPERATIVE INFECTION; PREOPERATIVE TREATMENT; PROTEUS MIRABILIS; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; TEACHING HOSPITAL;

ANTI-BACTERIAL AGENTS; COST SAVINGS; DATA COLLECTION; DRUG RESISTANCE; DRUG UTILIZATION; HOSPITALS, COMMUNITY; HOSPITALS, TEACHING; HUMANS; MEDICAL STAFF, HOSPITAL; PHYSICIAN'S PRACTICE PATTERNS; TEXAS;

EID: 33645577989     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/500419     Document Type: Article

References (18)

1. McGowan JE, Tenover FC. Control of antimicrobial resistance in the health care system. Infect Dis Clin North Am 1997; 11:297-311.
2. Schwartz B, Bell DM, Hughes JM. Preventing the emergence of antimicrobial resistance: a call for action by clinicians, public health officials, and patients. JAMA 1997; 278:944-945.
3. Fraser GL, Stogsdill P, Dickens JD, et al. Antibiotic optimization: an evaluation of patient safety and economic outcomes. Arch Intern Med 1997; 157:1689-1694.
4. Pelletier LL. Hospital usage of patenteral antimicrobial agents: a gradated utilization review and cost containment program. Infect Control 1985; 6:226-230.
5. Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis 1988; 157:869-876.
6. Dunagan WC, Woodward RS, Medoff G, et al. Antimicrobial misuse in patients with positive blood cultures. Am J Med 1989; 87:253-259.
7. McGowan JE. Do intensive antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994; 15:478-483.
8. Arbo MD, Snydman DR. Influence of blood culture results on antibiotic choice in the treatment of bacteremia. Arch Intern Med 1994; 154:2641-2645.
9. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals: a challenge to hospital leadership. JAMA 1996; 275:234-240.
10. Abramson MA, Sexton DJ. Nosocomial methicillin-resistant and methicillin-sensitive Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol 1999; 20:408-411.
11. Shlaes DM, Gerding DN, John JF, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997; 25:584-599.
12. Patterson JE, Hardin TC, Kelly CA, et al. Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol 2000; 21:455-458.
13. White AC, Atmar RL, Wilson J, et al. Effects of requiring prior authorization for selected antimicrobials: expenditures, susceptibilities, and clinical outcomes. Clin Infect Dis 1997; 25:230-239.
14. Smith DW. Decreased antimicrobial resistance after changes in antibiotic use. Pharmacotherapy 1999; 19(8 pt 2):129S-132S.
15. Antimicrobial prophylaxis in surgery. Med Lett Drugs Ther 2001; 43:92-97.
16. American Society of Health-System Pharmacists. ASHP Therapeutic Guidelines on Antimicrobial Prophylaxis in Surgery. Am J Health Syst Pharm 1999; 56:1839-1888.
17. Mangram AJ, Horan TC, Pearson ML, et al. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999; 20:250-278.
18. NNIS System. National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 2003; 31:481-498.